Maria Fardis
2019
In 2019, Maria Fardis earned a total compensation of $4.1M as President and Chief Executive Officer at Lion Biotechnologies, a 56% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $600,000 |
|---|---|
| Option Awards | $2,907,960 |
| Salary | $600,000 |
| Total | $4,107,960 |
Fardis received $2.9M in option awards, accounting for 71% of the total pay in 2019.
Fardis also received $600K in non-equity incentive plan and $600K in salary.
Rankings
In 2019, Maria Fardis' compensation ranked 2,882nd out of 13,971 executives tracked by ExecPay. In other words, Fardis earned more than 79.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,882 out of 13,971 | 79th |
Division Manufacturing | 1,040 out of 5,701 | 82nd |
Major group Chemicals And Allied Products | 346 out of 2,200 | 84th |
Industry group Drugs | 283 out of 1,886 | 85th |
Industry Biological Products, Except Diagnostic Substances | 67 out of 389 | 83rd |
Source: SEC filing on April 27, 2021.
Fardis' colleagues
We found three more compensation records of executives who worked with Maria Fardis at Lion Biotechnologies in 2019.